Sex Differences in Long-Term Survival after a First Stroke with Intravenous Thrombolysis: Ebrictus Study

José Luis Clua-Espuny, Rosa Ripolles-Vicente, Teresa Forcadell-Arenas, Vicente Francisco Gil-Guillen, Maria Lluïsa Queralt-Tomas, María Antonia González-Henares, Anna Panisello-Tafalla, Carlos López-Pablo, Jorgina Lucas-Noll, Ebrictus Group, José Luis Clua-Espuny, Rosa Ripolles-Vicente, Teresa Forcadell-Arenas, Vicente Francisco Gil-Guillen, Maria Lluïsa Queralt-Tomas, María Antonia González-Henares, Anna Panisello-Tafalla, Carlos López-Pablo, Jorgina Lucas-Noll, Ebrictus Group

Abstract

Background: A number of large trials have confirmed the benefits of thrombolysis in acute stroke, but there are gender differences. We sought to examine the relationship between sex and outcome after thrombolysis.

Methods: This was a prospective cohort study including 1,272 incident ischemic strokes (597 in women) from April 1, 2006 to December 31, 2014. Statistical approaches were used for analyzing survival outcomes and their relationship with thrombolysis therapy.

Results: The death rates were lower (p = 0.003) in the thrombolysis therapy group with an incidence ratio of 0.57 (95% CI 0.39-0.83). 113 (8.8%) patients (53 women) received thrombolysis. They were significantly younger (69.2 ± 12.7 vs. 73.9 ± 12.5 years; p < 0.001), had higher NIHSS score (12.7 ± 6.3 vs. 7.3 ± 7.0; p < 0.001), spent more days in hospital (10.4 ± 8.3 vs. 8.3 ± 7.9; p < 0.001), and had a higher average Barthel score at discharge (85.5 ± 24.4 vs. 79.2 ± 28.6; p = 0.023). The male/female incidence ratio showed a significant decrease (p = 0.01) in the incidence of mortality in women and a better Barthel score. The thrombolysis improved the survival in the overall group with thrombolysis versus without thrombolysis (p = 0.028), in women versus in men with thrombolysis (p = 0.023), and in women with thrombolysis versus in those without thrombolysis (p < 0.001) but not in men with thrombolysis versus in those without thrombolysis (p = 0.743). The protective factors as regards mortality were thrombolysis therapy (95% CI 0.37-0.80; p = 0.002), Barthel score ≥ 60 (95% CI 0.81-0.94; p = 0.002), and cardiovascular secondary prevention 1 year after stroke (0.13, 95% CI 0.06-0.28).

Conclusions: The stroke death rates were lower in women after thrombolysis treatment and suggest significant benefit for women in this setting. The overall benefit on survival of the patients treated with thrombolysis might be explained by the beneficial effect of the thrombolysis on the women.

Keywords: Acute ischemic stroke; Incidence; Intravenous thrombolysis; Mortality; Sex; Survival.

Figures

Fig. 1
Fig. 1
Survival curve by gender: all with thrombolysis.
Fig. 2
Fig. 2
Survival curve of the women: with versus without thrombolysis.
Fig. 3
Fig. 3
Survival curve of the men: with versus without thrombolysis.

References

    1. Eriksson M, Glader E-L, Norrving B, Terént A, Stegmayr B. Sex differences in stroke care and outcome in the Swedish national quality register for stroke care. Stroke. 2009;40:909–914.
    1. Förster A, Gass A, Kern R, Wolf ME, Ottomeyer C, Zohsel K, Hennerici M, Szabo K. Gender differences in acute ischemic stroke: etiology, stroke patterns and response to thrombolysis. Stroke. 2009;40:2428–2432.
    1. Lorenzano S, Ahmed N, Falcou A, Mikulik R, Tatlisumak T, Roffe C, Wahlgren N, Toni D, on behalf of the SITS Investigators Does sex influence the response to intravenous thrombolysis in ischemic stroke? Stroke. 2013;44:3401–3406.
    1. Gargano JW, Reeves MJ, for the Paul Coverdell National Acute Stroke Registry Michigan Prototype Investigators Sex differences in stroke recovery and stroke-specific quality of life: results from a statewide stroke registry. Stroke. 2007;38:2541–2548.
    1. Niewada M, Kobayashi A, Sandercock PA, Kaminski B, Czlonkowska A. Influence of gender on baseline features and clinical outcomes among 17,370 patients with confirmed ischaemic stroke in the international stroke trial. Neuroepidemiology. 2005;24:123–128.
    1. Kent DM, Buchan AM, Hill MD. The gender effect in stroke thrombolysis. Of CASES, controls, and treatment-effect modification. Neurology. 2008;71:1080–1083.
    1. Meseguer E, Mazighi M, Labreuche J, Arnaiz C, Cabrejo L, Slaoui T, Guidoux C, Olivot J-M, Abboud H, Lapergue B, Raphaeli G, Klein IF, Lavallée PC, Amarenco P. Outcomes of intravenous recombinant tissue plasminogen activator therapy according to gender: a clinical registry study and systematic review. Stroke. 2009;40:2004–2010.
    1. Clua-Espuny JL, Piñol-Moreso JL, Panisello-Tafalla A, Lucas-Noll J, Gil-Guillen VF, Orozco-Beltran D, Queralt-Tomas ML. Estudio Ebrictus. Resultados funcionales, supervivencia y años potenciales de vida perdidos después del primer episodio de ictus (in Spanish) Aten Primaria. 2012;44:223–231.
    1. Clua-Espuny JL, Piñol-Moreso JL, Gil-Guillén JF, Orozco-Beltran D, Panisello-Tafalla A, Lucas-Noll J. La atención sanitaria del ictus en el área Terres de l'Ebre desde la implantación del Código Ictus: Estudio Ebrictus. Med Clín. 2012;138:609–611.
    1. Clua-Espuny JL, Garcés-Redondo M, Lucas-Noll J, Panisello-Tafalla A, Queralt-Tomas LL. Stroke epidemiology, survival and disability in a Mediterranean population according Malmgren's criteria. Ebrictus Cohort. Ann Vasc Med Res. 2014;1:1004.
    1. Clua-Espuny JL, Ripolles-Vicente R, Lopez-Pablo C, Panisello-Tafalla A, Lucas-Noll J, Calduch-Noll C, González-Henares MA, Queralt-Tomas ML. Diferencias en la supervivencia después de un episodio de ictus tratado con fibrinólisis. Estudio Ebrictus (in Spanish) Aten Primaria. 2015;47:108–116.
    1. Queralt-Tomas MLL. Coordination strategies of care across stroke recovery: proposals for nursing interventions in primary care. Clin Nurs Stud. 2015;3:81.
    1. Turtzo LC, McCullough LD. Sex differences in stroke. Cerebrovasc Dis. 2008;26:462–474.
    1. Mehndiratta P, Wasay M, Mehndiratta MM. Implications of female sex on stroke risk factors, care, outcome and rehabilitation: an Asian perspective. Cerebrovasc Dis. 2015;39:302–308.
    1. Lorenzano S, Ahmed N, Falcou A, Mikulik R, Tatlisumak T, Roffe C, Wahlgren N, Toni D, FESO on behalf of the SITS Investigators Does sex influence the response to intravenous thrombolysis in ischemic stroke?: answers from safe implementation of treatments in Stroke-International Stroke Thrombolysis Register. Stroke. 2013;44:3401–3406.
    1. Hametner C, Ringleb P, Kellert L. Sex and hemisphere – a neglected, nature-determined relationship in acute ischemic stroke. Cerebrovasc Dis. 2015;40:59–66.
    1. Clua-Espuny JLI, Piñol-Moreso JLI, Gil-Guillén VF, Orozco-Beltrán D, Panisello-Tafalla A, Lucas-Noll J, Queralt-Tomás ML, Pla-Farnós R. Resultados de prevención cardiovascular primaria y secundaria en pacientes con ictus. Riesgo de recurrencia y supervivencia asociada. Estudio Ebrictus. Rev Neurol. 2012;54:81–92.
    1. Eriksson M, Carlberg B, Eliasson M. The disparity in long-term survival after a first stroke in patients with and without diabetes persists: The Northern Sweden MONICA Study. Cerebrovasc Dis. 2012;34:153–160.
    1. Silva GS, Lima FO, Camargo ECS, Smith WS, Lev MH, Harris GJ, Halpern EF, Koroshetz W, Furie KL. Gender differences in outcomes after ischemic stroke: role of ischemic lesion volume and intracranial large-artery occlusion. Cerebrovasc Dis. 2010;30:470–475.
    1. Flynn D, Nesbitt DJ, Ford GA, McMeekin P, Rodgers H, Price C, Kray C, Thomson RG. Development of a computerised decision aid for thrombolysis in acute stroke care. BMC Med Inform Decis Mak. 2015;15:6.
    1. Khatri P, Hacke W, Fiehler J, Saver JL, Diener H-C, Bendszus M, Bracard S, Broderick J, Campbell B, Ciccone A, Schonewille WJ, Siddiqui AH, Thomalla G, Tomsick TA, Turk AS, White PM, Zaidat OO, Liebeskind DS, Fulton R, Lees KR. State of acute endovascular therapy: report from the 12th Thrombolysis, Thrombectomy, and Acute Stroke Therapy Conference. Stroke. 2015;46:1727–1734.
    1. Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A, San Roman L, Serena J, Abilleira S, Ribo M, Millan M, Urra X, Cardona P, Lopez-Cancio E, Tomasello A, Castano C, Blasco J, Aja L, Dorado L, Quesada H, Rubiera M, Hernandez-Perez M, Goyal M, Demchuk AM, von Kummer R, Gallofre M, Davalos A, for the REVASCAT Trial Investigators Thrombectomy within 8 h after symptom onset in ischemic stroke. N Engl J Med. 2015;372:2296–2306.
    1. Hennerici MG. Is there a new era for stroke therapy? Cerebrovasc Dis. 2015;40:I–II.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅